Brightree Launches Lockbox, an Automated Patient-Pay Service to Help HMEs Get Paid Faster

ATLANTA – October 24, 2017 – Brightree, the leading provider of cloud-based patient management software for post-acute care companies, today announced the release of Lockbox, an automated patient-pay service that helps home medical equipment providers (HMEs) receive funds faster, improve their cash flow, shorten their revenue cycle and save hours in staff time.

Lockbox provides an automated, high-speed document scanning process that replaces many of the manual steps that burden HME accounts receivable. With this process, Lockbox posts all bank funds and documents online, and applies the funds to the HME’s accounts receivable in Brightree.

“Lockbox helps solve one of HMEs’ top concerns: how to get paid faster,” said Shaw Rietkerk, executive vice president and general manager, Brightree Revenue Cycle Management. “At a time when many companies are dealing with rising labor costs and increased borrowing costs, our automation technology gives customers an attractive payment processing solution that improves their cash flow, saves time and money, and decreases the potential for errors.”

Brightree’s Lockbox service will be at shown at Medtrade on October 24-25, 2017. Visit Booth #710 for a consultation. Or read more about Lockbox and Brightree’s other Patient Collections solutions here.

Brightree, a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD), is the leading provider of cloud-based software to improve clinical and business performance of post-acute care companies. Ranked one of the top 100 healthcare IT companies in the U.S., Brightree serves more than 2,200 organizations in the HME, home health, hospice, orthotic and prosthetic, HME pharmacy, home infusion and rehabilitation home care segments. For more information, visit brightree.com or call 1.888.598.7797.

Brightree is a registered trademark of Brightree LLC.

Contacts

For media: Ken Pierannunzi 678.243.1062 kpierannunzi@brightree.com

For investors: Agnes Lee 858.836.5971 investorrelations@resmed.com